Pill power: early oral antibiotics may replace IV drips for blood infections
NCT ID NCT05199324
First seen Apr 17, 2026 · Last updated Jun 06, 2026 · Updated 8 times
Summary
This study tests whether stable hospital patients with a Gram-negative bloodstream infection can safely switch from intravenous (IV) antibiotics to oral pills within 72 hours, instead of continuing IV therapy. Researchers will compare death rates and other outcomes at 30 and 90 days. The goal is to see if early oral treatment works just as well, while potentially reducing hospital stays and costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM-NEGATIVE BACTERAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tan Tock Seng Hospital
RECRUITINGSingapore, Singapore, 308433, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.